Prevention of Transfusion Related Acute Lung Injury Using Riboflavin and Light
AssigneeCaridianBCT Biotechnologies, LLC
InventorsRaymond P. GOODRICH, Suzanne MARSCHNER
Life of this patent
Estimating the term…
Abstract
This invention is directed toward a method of preventing the formation of bioactive substances in a pathogen inactivated blood component. The steps include illuminating the blood component with light at a sufficient energy so that an alloxazine photosensitizer present in the blood component may be photolyzed to inactivate any pathogens which may be present; preventing the formation of bioactive substances in the pathogen inactivated blood component; and storing the pathogen inactivated blood component.
Claims7
A method of preventing the formation of bioactive substances in pathogen inactivated blood or blood component comprising the steps of;
- illuminating the blood or blood component with light at a sufficient energy so that an alloxazine photosensitizer present in the blood or blood component may be photolyzed to inactivate any pathogens which may be present;
- preventing the formation of bioactive substances in the pathogen inactivated blood or blood component;
- and
- storing the pathogen inactivated blood or blood component.
Dependencies are inferred from the claim text.